My treatment plan may change depending on the outcome of the treatment, especially if painkillers are ineffective. These drugs are stopped. My treatment plan includes: Informed consent provides a framework for the risk associated with treatment. In chronic opioid treatment (TOC) for patients with pain, the tool describes potential risks (e.g. B, the potential for dependence when taking controlled substances) and the benefits. Education and asking questions require an initial amount of time; However, these efforts ultimately save time. A patient is less likely to make unnecessary emergency appointments if they clearly understand what to expect from a medication or treatment and have a specific plan on what to do when pain breaks out. The importance of the agreement is reinforced by the fact that the patient signs to certify their understanding and the prescribing clinician signs to confirm that the agreement has been discussed. In the event that the patient deviates from this aspect of their care, the agreement provides a basis for discussing the consequences and possible solutions.

The law prescribes not only the existence of the treatment agreement and its contents, but also the steps that must be taken before prescribing opioids for chronic pain. Previous legislation, Bill 191 of 2014, required prescriptions to query the prescription drug monitoring database whenever a patient was prescribed an opioid. In addition, the prescribing physician must determine if the person is taking a prescription medication (p.B. Suboxon) for the treatment of substance use disorders (SUD), and in addition, personally discuss with the patient a number of issues that essentially constitute the patient`s informed consent: risks of dependence (especially if the patient has SUD), interactions with alcohol and other central nervous system (CNS) sedatives, important information about the labelling of the drug and, where applicable, non-opioid treatment Options in accordance with prescribing guidelines. In addition, a basic urine drug screening with quantitative follow-up tests for positive results must be performed before an opioid prescription for chronic pain is issued. The use of these agreements is not limited to pain management clinics, but extends to anyone who prescribes controlled substances. A Long-Term Study Describing the Long-Term Use of Opioid Contracts for Chronic Pain Management in Primary Care Practice: A Five-Year Experiment Illustrates the Broader Needs of This Type of Conversation Between Specialty Types. The written agreement does not replace or replace the prescribing physician and the patient in a dialogue. It simply provides a basis and structure for education and discussion and serves to document mutual understanding between the patient and the prescribing physician to enable safe care.

Treating chronic pain with opioids is complicated and difficult. Doctors need to know if patients can follow the treatment plan, if they get the desired answers from medications, and if there are signs of developing an addiction. And patients need to know the potential risks of opioids, as well as the expectations to minimize those risks. Doctors use “drug contracts” to ensure that patients and providers are on the same page before starting opioid treatment. Such agreements are most often used when narcotic analgesics are prescribed. .